Vir Biotechnology, Inc. (VIR) Form 8-K — Jun 10, 2026
Vir Biotechnology, Inc. announced the appointment of Timothy Coughlin, CPA, as a new independent director and Chair of the Audit Committee, effective June 9, 2026. The Board increased its size from seven to eight members to accommodate the new appointment, with Mr. Coughlin serving as a Class III director until the 2028 annual meeting.
Price after filing
1 day: +3.3%7 days: +12.7%30 days: +25.3%
Close on the filing date to close N calendar days later (from $8.25). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.